CoChat

Rational design of hypoallergens applied to the major cat allergen Fel d 1

Saarne, T., Kaiser, L., Grönlund, H., Rasool, O., Gafvelin, G., Van Hage‐Hamsten, M. · 2005 · Clinical & Experimental Allergy
Cited by 51

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Summary: Background Allergen‐specific immunotherapy is the only treatment for allergic disease providing long‐lasting symptom relief. Currently, it is mainly based on the use of crude allergen extracts. The treatment may be improved by the use of genetically engineered allergens, hypoallergens, aiming at a more effective and safer therapy. Objective The aim of this study was to provide a rational design of hypoallergen candidates for immunotherapy by using structural information and knowledge of B and T cell epitopes of an allergen. Methods The three‐dimensional structure of the major cat allergen Fel d 1 was systematically altered by duplication of selected T cell epitopes and disruption of disulphide bonds. Seven Fel d 1 derivatives were generated and screened for allergenic reactivity in comparison with recombinant Fel d 1 in competition‐ELISA. The allergenicity was further evaluated in basophil activation experiments and T cell reactivity was assessed in a lymphoproliferation assay. Results Three out of seven Fel d 1 derivatives, with two duplicated T cell epitopes and one or two disulphide bonds disrupted, were carefully evaluated. The three derivatives displayed a strong reduction in allergenicity with 400–900 times lower IgE‐binding capacity than recombinant Fel d 1. In addition, they induced a lower degree of basophil activation and similar or stronger T cell proliferation than recombinant Fel d 1. Conclusion By a rational approach, we have constructed three Fel d 1 hypoallergens with reduced IgE‐binding capacities and retained T cell reactivities. This strategy may be applied to any well‐characterized allergen to improve immunotherapy for allergic patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2222.2005.02234.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 51

Metadata

Authors
Saarne, T., Kaiser, L., Grönlund, H., Rasool, O., Gafvelin, G., & Van Hage‐Hamsten, M.
Venue
Clinical & Experimental Allergy
Publisher
Wiley
Published
2005-05
Volume
35
Issue
5
Pages
657-663
ISSN
  • 0954-7894 (ISSN-L)
  • 1365-2222
OpenAlex
W2148168526
Cited by
51
References
4
FWCI
2.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rational design of hypoallergens applied to the major cat allergen Fel d 1. https://app.cochat.ai/papers/10.1111/j.1365-2222.2005.02234.x
The paper
Saarne, T., Kaiser, L., Grönlund, H., Rasool, O., Gafvelin, G., & Van Hage‐Hamsten, M. (2005). Rational design of hypoallergens applied to the major cat allergen Fel d 1. Clinical & Experimental Allergy. https://doi.org/10.1111/j.1365-2222.2005.02234.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.